We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,952 results
  1. Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease

    Alzheimer disease (AD) is a leading cause of dementia in elderly patients who continue to live between 3 and 11 years of diagnosis. A steep rise in...

    Sudharsana Sundarrajan, Arthi Venkatesan, ... Hatem Zayed in Metabolic Brain Disease
    Article Open access 10 May 2023
  2. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

    Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of approximately 70% 1 . The genetic component of AD has been...

    Henne Holstege, Marc Hulsman, ... Jean-Charles Lambert in Nature Genetics
    Article Open access 21 November 2022
  3. AD Blank Spot Model for Evaluation of Alzheimer’s Disease

    The discovery of biomarkers that confer high confidence of Alzheimer’s disease (AD) diagnosis and disease management would be a valuable tool to...
    Antigoni Avramouli, Panagiotis M. Vlamos in Handbook of Computational Neurodegeneration
    Living reference work entry 2023
  4. AD Blank Spot Model for Evaluation of Alzheimer’s Disease

    The discovery of biomarkers that confer high confidence of Alzheimer’s disease (AD) diagnosis and disease management would be a valuable tool to...
    Antigoni Avramouli, Panagiotis Vlamos in Handbook of Computational Neurodegeneration
    Reference work entry 2023
  5. Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes

    Early-onset dementia (EOD), with symptom onset before age 65, has a strong genetic burden. Due to genetic and clinical overlaps between different...

    Sara Silvaieh, Theresa König, ... Alexander Zimprich in Human Genomics
    Article Open access 17 June 2023
  6. An overview of early-onset cerebellar ataxia: a practical guideline

    Early onset ataxias (EOAs) are a heterogeneous group of rare neurological disorders that not only involve the central and peripheral nervous system...

    Sareh Hosseinpour, Maryam Bemanalizadeh, ... Morteza Heidari in Acta Neurologica Belgica
    Article 01 July 2024
  7. Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease

    The search for rare variants in Alzheimer’s disease (AD) is usually deemed a high-risk - high-reward situation. The challenges associated with this...

    Marzieh Khani, Elizabeth Gibbons, ... Rita Guerreiro in Molecular Neurodegeneration
    Article Open access 09 January 2022
  8. Gene Panel Sequencing Analysis Revealed a Strong Contribution of Rare Coding Variants to the Risk of Parkinson’s Disease in Sporadic Moroccan Patients

    Parkinson’s disease (PD) is a neurodegenerative movement disorder which can be either familial or sporadic. While it is well known that monogenic...

    Imane Smaili, Houyam Tibar, ... Ahmed Bouhouche in Journal of Molecular Neuroscience
    Article 31 May 2023
  9. Probability of Alzheimer’s disease based on common and rare genetic variants

    Background

    Alzheimer’s disease, among other neurodegenerative disorders, spans decades in individuals’ life and exhibits complex progression, symptoms...

    Valentina Escott-Price, Karl Michael Schmidt in Alzheimer's Research & Therapy
    Article Open access 17 August 2021
  10. A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease

    Late-onset Alzheimer’s disease (LOAD) is the most common form of dementia, and its pathogenesis is multifactorial. We previously reported a rare...

    Yuya Asanomi, Daichi Shigemizu, ... Kouichi Ozaki in Journal of Human Genetics
    Article Open access 05 November 2021
  11. Map** the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families

    Background

    Many families with clinical early-onset Alzheimer’s disease (EOAD) remain genetically unexplained. A combination of genetic factors is not...

    Merel O. Mol, Sven J. van der Lee, ... Jeroen G. J. van Rooij in Alzheimer's Research & Therapy
    Article Open access 01 June 2022
  12. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia

    The TREM2–DAP12 receptor complex sustains microglia functions. Heterozygous hypofunctional TREM2 variants impair microglia, accelerating late-onset...

    Yingyue Zhou, Mari Tada, ... Marco Colonna in Nature Immunology
    Article 19 January 2023
  13. Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

    Background

    A substantial number of patients clinically diagnosed with Alzheimer’s disease do not harbor amyloid pathology. We analyzed the presence...

    Eddie C. Stage Jr, Diana Svaldi, ... Liana G. Apostolova in Alzheimer's Research & Therapy
    Article Open access 05 August 2020
  14. A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

    Background

    The Colombian population, as well as those in other Latin American regions, arose from a recent tri-continental admixture among Native...

    Juliana Acosta-Uribe, David Aguillón, ... Kenneth S. Kosik in Genome Medicine
    Article Open access 08 March 2022
  15. Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology

    Recent evidence suggests that Alzheimer’s disease (AD) genetic risk variants (rs1582763 and rs6591561) of the MS4A locus are genome-wide significant...

    Rebecca L. Winfree, Emma Nolan, ... Timothy J. Hohman in Molecular Neurodegeneration
    Article Open access 18 May 2024
  16. Rare missense mutations in ABCA7 might increase Alzheimer’s disease risk by plasma membrane exclusion

    The adenosine triphosphate–binding cassette subfamily A member 7 gene ( ABCA7) is associated with Alzheimer’s disease (AD) in large genome-wide...

    Liene Bossaerts, Elisabeth Hendrickx Van de Craen, ... Christine Van Broeckhoven in Acta Neuropathologica Communications
    Article Open access 31 March 2022
  17. Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

    Alzheimer’s disease (AD) is characterized pathologically by amyloid-beta (Aβ) deposition in brain parenchyma and blood vessels (as cerebral amyloid...

    Gargi Banerjee, Simon F. Farmer, ... John Collinge in Nature Medicine
    Article Open access 29 January 2024
  18. Driving mosaicism: somatic variants in reference population databases and effect on variant interpretation in rare genetic disease

    Background

    Genetic variation databases provide invaluable information on the presence and frequency of genetic variants in the ‘untargeted’ human...

    Vladimir Avramović, Simona Denise Frederiksen, ... Maja Tarailo-Graovac in Human Genomics
    Article Open access 14 December 2021
  19. The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson’s disease in mainland China

    So far, over 20 causative genes of monogenic Parkinson’s disease (PD) have been identified. Some causative genes of non-parkinsonian entities may...

    Yi-Min Sun, **n-Yue Zhou, ... Jian Wang in npj Parkinson's Disease
    Article Open access 17 May 2023
  20. Novel autosomal dominant TMC1 variants linked to hearing loss: insight into protein-lipid interactions

    Background

    TMC1 , which encodes transmembrane channel-like protein 1, forms the mechanoelectrical transduction (MET) channel in auditory hair cells,...

    Sung Ho Cho, Ye** Yun, ... Sang-Yeon Lee in BMC Medical Genomics
    Article Open access 08 December 2023
Did you find what you were looking for? Share feedback.